Cited by 1Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancerSphingolipid Metabolism and Signaling

From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease

Open access
Mishra, Subrata H., Chatterjee, Sujan, Viera-Preval, Loretta, Guha, Prasun·2025·Biomolecules

Abstract

Once a protein of relative obscurity, inositol polyphosphate multikinase (IPMK) emerged as a versatile and indispensable enzyme in cellular biology. With dual inositol and lipid kinase activities, IPMK generates pivotal signaling molecules such as InsP4 (inositol tetraphosphate), InsP5 (inositol pentaphosphate), and PIP3 (phosphoinositide 3,4,5-trisphosphate), positioning it as a critical regulator of cellular mechanisms. Initially identified in yeast and later recognized as essential for mammalian embryonic development, IPMK has transitioned from a niche interest to a focal point in studies of nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation. Over two decades, multidisciplinary research has unveiled its far-reaching biological roles and implications in diverse diseases, including neurodegeneration, cancer, and inflammation. This review charts IPMK’s journey from obscurity to prominence, examining its structure–function relationships, cellular roles, and emerging physiological impacts, while highlighting its potential as a therapeutic target in human health and disease.

AI snapshot

Written from the paper’s full text.

TL;DR

This review traces inositol polyphosphate multikinase (IPMK) from a little-studied enzyme to a central regulator of cellular signaling, arguing that its dual inositol- and lipid-kinase activities plus kinase-independent scaffolding functions place it at the intersection of nutrient sensing, transcription, autophagy, immunity, and disease. The authors synthesize two decades of structural, cellular, and animal-model work and highlight IPMK as a candidate therapeutic target.

Key findings

  • IPMK is a dual-specificity enzyme: it acts as a 6-/3-inositol kinase generating InsP4 and InsP5 (and, indirectly, InsP6–InsP8) and as a lipid kinase that selectively converts PIP2 to PIP3, unlike class I PI3K, which produces multiple phosphoinositide products.
  • Among HOIP-pathway enzymes, IPMK is the only one whose deletion causes embryonic lethality in mice; homozygous null mutants show developmental delays and lethality by embryonic days 9.5–10, with failure of allantois–chorion fusion, absent somites, and neural tube folding/kinking defects.
  • IPMK loss reduces InsP5 and InsP6 levels across organisms and impairs diverse processes: cell migration (via PDK1/ROCK1/MLC and integrin-linked mechanisms), AKT activation and proliferation in intestine and liver, nuclear PIP3-dependent DNA repair and p53-mediated survival, HDAC3 activation and histone acetylation, and autophagy (via an IPMK/ULK/AMPK complex).
  • Disease links include GWAS association with inflammatory bowel disease, a germline 4 bp IPMK deletion in familial small-intestine neuroendocrine tumors (not replicated in later cohorts), reduced IPMK in Huntington's and Alzheimer's samples, and roles in Treg, Th1/Th17, B-cell, and macrophage immune responses.
  • Structural work: human IPMK is 416 amino acids with N- and C-lobes joined by a hinge; the two deposited crystal structures agree with a backbone RMSD of 0.48 Å, and inhibitor screening has yielded two candidates, quercetin and vilazodone, targeting the ATP-binding site.

Methods

  • Narrative review, not primary research: the authors synthesize published structural, biochemical, cell-culture, animal-model, and human genetic literature on IPMK.
  • Structural evidence draws on deposited human IPMK crystal structures (PDB 5w2g, 6e7f) and mutational analyses tabulated by residue (e.g., Q78, R82, D144, K146, K160, Q163, Q164, K167, Q196, D385, H388) and their effects on 3- versus 6-kinase activity.
  • Disease and physiology sections compile mouse knockout models (whole-body, intestine-, hepatocyte-, Treg-, CD4-, B-cell-, and Nestin-Cre-specific), Drosophila, Dictyostelium, yeast, and human GWAS/mutation studies.

Limitations

  • Stated by the authors: a significant knowledge gap remains about IPMK's primary regulatory pathway in cellular homeostasis and which physiological functions it principally regulates; IPMK's precise intracellular distribution is underexplored, hampered by the lack of validated antibodies for endogenous protein; whether IPMK loss impairs only HDAC3 or also HDAC1/sirtuins is unresolved; the role of InsP6 in activating versus inhibiting mTORC1/2 is unclear; and the mechanism of IPMK's role in neural tube development is unexplored.
  • Stated by the authors: conflicting results exist on gut permeability after IPMK deletion (Park et al. found no change; Chatterjee et al. found a significant increase), which the authors attribute to differing degrees of backcrossing (five vs. ten generations) and possible residual donor alleles or microbiome differences.
  • Evident from the text: many mechanistic claims rest on overexpression systems, dominant-negative IPMK fragments whose boundaries were chosen by exon limits rather than structure, and crystal constructs that delete the disordered ~60 N-terminal residues and the NLS region (residues 263–377 in 5w2g, 279–373 in 6e7f), which the authors note alters ATP binding, InsP3 affinity, and kinetic parameters; the review itself reports no new experimental data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/biom15091266

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

147 of 187 cited sources checked · 66 supported · 2 flagged · accuracy not yet measured

  • Premisecitation

    Among all enzymes in the HOIP pathway, IPMK is the only one whose deletion leads to embryonic lethality in mice.

    “Notably, among all enzymes in the HOIP pathway, IPMK stands out as the only one whose deletion leads to embryonic lethality in mice, underscoring its critical role in mammalian development [25].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [25] Frederick, 2005, An Essential Role for an Inositol Polyphosphate Multikinase, Ipk2, in Mouse Embryogenesis and Second Messenger Production, Proc. Natl. Acad. Sci. USA source

      The Discussion (page not supplied) confirms that Ipk2/IPMK deletion is embryonically lethal, but explicitly reports a similar lethal phenotype for Ipk1-null mice. Thus the paper contradicts the claim that IPMK is the only enzyme in this pathway whose deletion causes embryonic lethality. (LLM, conf=0.93)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Premisecitation

    InsP6 can undergo further phosphorylation to form InsP7/8 by InsP6 kinases 1/2/3.

    “InsP6 can undergo further phosphorylation to form InsP7/8 by InsP6 kinases 1/2/3 [10].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [10] Chakraborty, 2011, Inositol Pyrophosphates as Mammalian Cell Signals, Sci. Signal. source

      The Introduction (page not provided) says the three mammalian IP6 kinases generate 5-IP7 from IP6. It says a different enzyme, PP-IP5K, is primarily responsible for IP8 formation in mammals, so attributing both products to IP6 kinases 1/2/3 overstates the source. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    ITPK1 can utilize Glucose-6-phosphate-derived InsP3 to generate InsP4 (InsP 1,3,4,5).

    “However, recent findings [38] suggest that ITPK1 can utilize Glucose-6-phosphate-derived InsP3 to generate InsP4 (InsP 1,3,4,5), and both isoforms of InsP4 are converted to InsP5 (InsP 1,3,4,5,6) exclusively by IPMK.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [38] Wilson, 2019, ITPK1 Mediates the Lipid-Independent Synthesis of Inositol Phosphates Controlled by Metabolism, Proc. Natl. Acad. Sci. USA source

      The Results section, “ITPK1 Can Use I(3)P1 to Generate Higher IPs” (page unavailable), reports that ITPK1 can use a glucose-6-phosphate-derived substrate to make higher inositol phosphates. But it identifies that substrate as I(3)P1, not InsP3, and does not establish that the product is specifically InsP(1,3,4,5)P4. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    In mammalian cells, InsP5 and InsP6 are produced in significantly higher concentrations compared to other inositol phosphates.

    “In mammalian cells, InsP5 and InsP6 are produced in significantly higher concentrations compared to other inositol phosphates [39,40], representing the highest products in the HOIP pathway.”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [39] Letcher, 2008, Do Mammals Make All Their Own Inositol Hexakisphosphate?, Biochem. J. source

      The Results (Table 1; page not provided) quantify InsP6 in rat tissues and HeLa cells, and the Introduction describes InsP5 as an intermediate in InsP6 synthesis. The paper does not establish that either compound is present at significantly higher concentrations than other inositol phosphates; its Discussion says the assay was not designed to quantify lower inositol phosphates. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [40] Stuart, 1994, The Intracellular Distribution of Inositol Polyphosphates in HL60 Promyeloid Cells, Biochem. J. source
  • Premisecitation

    The N-lobe and C-lobe interface form a groove-like cavity that harbors the catalytic site, facilitating transfer of phosphates from ATP to inositol head groups of PIP2 and InsP3, InsP4.

    “The N-lobe and the C-lobe interface form a groove-like cavity that harbors the catalytic site, which facilitates the transfer of phosphates from ATP to inositol head groups of PIP2 and InsP3, InsP4.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [41] Seacrist, C.D., and Blind, R.D. (2018). Crystallographic and Kinetic Analyses of Human IPMK Reveal Disordered Domains Modulate ATP Binding and Kinase Activity. Sci. Rep., 8. source

      The Results section (‘Crystallography shows ΔIPMK maintains the ATP-grasp fold’; page unavailable) describes N- and C-terminal domains, and the Methods (‘IPMK Kinase Assays’; page unavailable) document transfer of radiolabeled phosphate from ATP to PIP2. Our copy does not establish that their interface forms the claimed groove-like catalytic cavity or specifically identify InsP3 and InsP4 as substrates in that cavity. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [42] Wang, 2017, Structural Features of Human Inositol Phosphate Multikinase Rationalize Its Inositol Phosphate Kinase and Phosphoinositide 3-Kinase Activities, J. Biol. Chem. source
  • May combine two claims. 30
  • Classified as probably not a substantial claim. 18
  • May combine two claims.

    Premisecitation

    Under genotoxic stress, IPMK-generated nuclear PIP3 binds to p53, which activates nuclear AKT signaling and suppresses apoptosis.

    “While years of research have primarily investigated AKT signaling at the cell membrane, recent works by Chen et al. [71] and Choi et al. [61] have revealed that, under genotoxic stress, IPMK-generated nuclear PIP3 binds to p53, which activates nuclear AKT signaling and suppresses apoptosis.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [71] Chen, 2022, A P53-Phosphoinositide Signalosome Regulates Nuclear AKT Activation, Nat. Cell Biol. source
    • cites [61] Choi, 2019, A Nuclear Phosphoinositide Kinase Complex Regulates P53, Nat. Cell Biol. source

      The Discussion describes a different mechanism under genotoxic stress: PIPKIα generates PI4,5P2, which binds p53 and recruits small heat shock proteins that stabilize it. The Results likewise identify nuclear PI4,5P2—not IPMK-generated PIP3—as the lipid associated with p53. The cited paper does not describe this interaction as activating nuclear AKT signaling or suppressing apoptosis. Page numbers are unavailable in our copy. (LLM, conf=0.88)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The HOIP pathway uses InsP3 as a precursor and involves a series of phosphorylation events catalyzed by various kinases.

    “The HOIP pathway, which uses InsP3 as a precursor, involves a series of phosphorylation events catalyzed by various kinases [10,11] (Figure 1).”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [10] Chakraborty, 2011, Inositol Pyrophosphates as Mammalian Cell Signals, Sci. Signal. source
    • cites [11] Kim, 2016, IPMK: A Versatile Regulator of Nuclear Signaling Events, Adv. Biol. Regul. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Aberrant InsP3 signaling is implicated in cancer and neurological disorders.

    “Moreover, aberrant InsP3 signaling has been implicated in various pathological conditions, including cancer [7,8] and neurological disorders [9].”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [7] Marchi, 2020, Ca2+ Fluxes and Cancer, Mol. Cell source
    • cites [8] Kuchay, 2017, PTEN Counteracts FBXL2 to Promote IP3R3- and Ca2+-Mediated Apoptosis Limiting Tumour Growth, Nature source
    • cites [9] Metwally, 2021, The Calcium-Dependent Protease Calpain in Neuronal Remodeling and Neurodegeneration, Trends Neurosci. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    IPPK converts InsP5 into InsP6.

    “Subsequently, inositol pentakisphosphate 2-kinase (IPPK) converts InsP5 into InsP6 (Ins 1,2,3,4,5,6) [10].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [10] Chakraborty, 2011, Inositol Pyrophosphates as Mammalian Cell Signals, Sci. Signal. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    InsP3 mobilizes intracellular calcium release from the endoplasmic reticulum.

    “Since Michael Berridge and colleagues’ seminal discovery in 1983 [2] that InsP3 mobilizes intracellular calcium release from the endoplasmic reticulum [1,2,3], extensive research has illuminated InsP3’s crucial roles in regulating diverse physiological processes.”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [1] Berridge, 1984, Inositol Trisphosphate, a Novel Second Messenger in Cellular Signal Transduction, Nature source
    • cites [2] Berridge, 1983, Changes in the Levels of Inositol Phosphates after Agonist-Dependent Hydrolysis of Membrane Phosphoinositides, Biochem. J. source

      The Abstract and Discussion report that calcium-signalling agonists stimulate phosphoinositide hydrolysis and production of Ins(1,4,5)P3. They do not state that InsP3 itself releases calcium from the endoplasmic reticulum. Searches for intracellular calcium release and the endoplasmic reticulum found no passage establishing that attributed discovery. (LLM, conf=0.77)

      Experimental — accuracy not yet measured
    • cites [3] Burgess, 1984, The Second Messenger Linking Receptor Activation to Internal Ca Release in Liver, Nature source
  • May combine two claims.

    Premisecitation

    IPMK is involved in inflammatory disorders, obesity, Alzheimer's disease, inflammatory bowel disease, and intestinal neuroendocrine tumors.

    “Over the past two decades, research utilizing animal models and human mutation analyses has revealed IPMK’s involvement in a wide array of human diseases, including inflammatory disorders [28,29], obesity [30,31], Alzheimer’s disease [32], inflammatory bowel disease [33,34], and intestinal neuroendocrine tumors [35].”
    Quote in the paperSubstantial claim7 of 8 sources checked
    • cites [28] Ahn, 2021, Myeloid IPMK Promotes the Resolution of Serum Transfer-Induced Arthritis in Mice, Anim. Cells Syst. source
    • cites [29] Kim, 2017, Inositol Polyphosphate Multikinase Promotes Toll-like Receptor-Induced Inflammation by Stabilizing TRAF6, Sci. Adv. source
    • cites [30] Bang, 2014, Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action, Mol. Endocrinol. source

      The Discussion links IPMK to glucose metabolism, familial type 2 diabetes, and metformin-responsive AMPK signaling, but does not establish its involvement in obesity. Searches for obesity and the other listed diseases found no passage connecting IPMK to them; the reference to obese mice concerns a metformin study, not an IPMK finding. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [31] Lee, 2020, Inositol Polyphosphate Multikinase in Adipocytes Is Dispensable for Regulating Energy Metabolism and Whole Body Metabolic Homeostasis, Am. J. Physiol. Endocrinol. Metab. source
    • cites [32] Yokoyama, 2016, Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease, JAMA Neurol. source
    • cites [33] Park, 2022, Gut Epithelial Inositol Polyphosphate Multikinase Alleviates Experimental Colitis via Governing Tuft Cell Homeostasis, Cell. Mol. Gastroenterol. Hepatol. source
    • cites [34] Reilly, 2023, Loss of PI3k Activity of Inositol Polyphosphate Multikinase Impairs PDK1-Mediated AKT Activation, Cell Migration, and Intestinal Homeostasis, iScience source
    • cites [35] Sei, 2015, A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase, Gastroenterology source
  • May combine two claims.

    Premisecitation

    IPMK functions as both an inositol kinase and a lipid kinase, converting PIP2 to PIP3.

    “It functions as both an inositol kinase and a lipid kinase, capable of converting PIP2 (Phosphoinositide 4,5 bi phosphate) to PIP3 (Phosphoinositide 3,4,5 triphosphate) [26,27].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [26] Resnick, 2005, Inositol Polyphosphate Multikinase Is a Nuclear PI3-Kinase with Transcriptional Regulatory Activity, Proc. Natl. Acad. Sci. USA source
    • cites [27] Resnick, 2008, Inositol Polyphosphate Multikinase: Metabolic Architect of Nuclear Inositides, Front. Biosci. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The protein constructs in these crystal structures deviate from wild-type human IPMK sequence as they exclude the NLS region, replaced by a short artificial linker.

    “The protein constructs in these crystal structures deviate from the wild-type human IPMK sequence as they exclude the region encompassing the NLS region (residues 263–377 in pdb id 5w2g, 279–373 in pdb id 6e7f), which is replaced by a short artificial linker, to aid the crystallization of this protein.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [41] Seacrist, C.D., and Blind, R.D. (2018). Crystallographic and Kinetic Analyses of Human IPMK Reveal Disordered Domains Modulate ATP Binding and Kinase Activity. Sci. Rep., 8. source

      The Results state that the internal loop contains a nuclear localization signal and that the 6E7F construct replaces residues 279–373 with a short artificial linker. The Methods say the linker was required for crystallization. The Discussion mentions the similar but non-identical 5W2G construct, but our copy does not establish the claimed 263–377 boundaries or linker replacement for that structure. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [42] Wang, 2017, Structural Features of Human Inositol Phosphate Multikinase Rationalize Its Inositol Phosphate Kinase and Phosphoinositide 3-Kinase Activities, J. Biol. Chem. source

      The “Structure of human IPMK” section says residues 263–377, which contain a nuclear localization sequence, were deleted and replaced with a Gly-Gly-Ser-Gly-Gly linker to obtain crystals. The paper identifies 5W2G among its deposited structures, but our copy does not establish the claimed deletion of residues 279–373 in 6E7F. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK functions in mRNA export, chromatin remodeling, transcription, nutrient sensing, and growth factor signaling.

    “Its diverse functions span a wide range of cellular processes, including mRNA export [17,18], chromatin remodeling [19,20], transcription [21,22], nutrient sensing [23], and growth factor signaling [15].”
    Quote in the paperSubstantial claim6 of 8 sources checked
    • cites [15] Maag, 2011, Inositol Polyphosphate Multikinase Is a Physiologic PI3-Kinase That Activates Akt/PKB, Proc. Natl. Acad. Sci. USA source
    • cites [17] Wickramasinghe, 2013, Human Inositol Polyphosphate Multikinase Regulates Transcript-Selective Nuclear MRNA Export to Preserve Genome Integrity, Mol. Cell source
    • cites [18] Saiardi, 2000, Inositol Polyphosphate Multikinase (ArgRIII) Determines Nuclear MRNA Export in Saccharomyces Cerevisiae, FEBS Lett. source
    • cites [19] Steger, 2003, Regulation of Chromatin Remodeling by Inositol Polyphosphates, Science source
    • cites [20] Beon, 2022, Inositol Polyphosphate Multikinase Physically Binds to the SWI/SNF Complex and Modulates BRG1 Occupancy in Mouse Embryonic Stem Cells, Elife source
    • cites [21] Blind, 2012, Direct Modification and Activation of a Nuclear Receptor-PIP2 Complex by the Inositol Lipid Kinase IPMK, Sci. Signal. source

      The citation [15] is attached to “growth factor signaling,” so that is the part assessed. The Introduction discusses IPMK’s lipid-kinase activity and transcriptional roles, but neither it nor the passages found by searching for growth factors and Akt states that IPMK functions in growth factor signaling. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
    • cites [22] Xu, 2013, Inositol Polyphosphate Multikinase Is a Transcriptional Coactivator Required for Immediate Early Gene Induction, Proc. Natl. Acad. Sci. USA source
    • cites [23] Kim, 2011, Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase, Cell Metab. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    InsP3 regulates muscle contraction, synaptic transmission, and embryonic development.

    “These include muscle contraction [4], synaptic transmission [5], and embryonic development [6].”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [4] Kuo, I.Y., and Ehrlich, B.E. (2015). Signaling in Muscle Contraction. Cold Spring Harb. Perspect. Biol., 7. source
    • cites [5] Kaplan, 2001, PI-3 Kinase and IP3: Partners in NT3-Induced Synaptic Transmission, Nat. Neurosci. source
    • cites [6] Yang, F., Huang, L., Tso, A., Wang, H., Cui, L., Lin, L., Wang, X., Ren, M., Fang, X., and Liu, J. (2020). Inositol 1,4,5-Trisphosphate Receptors Are Essential for Fetal-Maternal Connection and Embryo Viability. PLoS Genet., 16. source
  • May combine two claims.

    Premisecitation

    IPMK is a dual-specificity 6-/3-kinase that generates InsP4 and InsP5 species.

    “A key enzyme in this pathway is inositol polyphosphate multikinase (IPMK), a dual-specificity 6-/3-kinase that generates InsP4 and InsP5 species [11,12].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [11] Kim, 2016, IPMK: A Versatile Regulator of Nuclear Signaling Events, Adv. Biol. Regul. source
    • cites [12] Saiardi, 1999, Synthesis of Diphosphoinositol Pentakisphosphate by a Newly Identified Family of Higher Inositol Polyphosphate Kinases, Curr. Biol. source

      The Results and discussion identify ArgRIII as IPMK and report that it phosphorylates InsP3 and InsP4, producing higher inositol polyphosphates; this supports generation of InsP4 and InsP5. The passages do not establish that IPMK phosphorylates specifically at both the 6 and 3 positions, so the dual-specificity 6-/3-kinase description is not supported by our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK has roles in nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation.

    “Initially identified in yeast and later recognized as essential for mammalian embryonic development, IPMK has transitioned from a niche interest to a focal point in studies of nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation.”
    Quote in the paperSubstantial claim6 of 8 sources checked
    • cites [15] Maag, 2011, Inositol Polyphosphate Multikinase Is a Physiologic PI3-Kinase That Activates Akt/PKB, Proc. Natl. Acad. Sci. USA source

      The introduction and Results and Discussion support IPMK’s role in growth factor–dependent Akt signaling, and the paper notes that IPMK deletion is lethal early in mouse embryogenesis. Our copy does not establish roles in nutrient sensing or mRNA transport. Transcriptional regulation appears in the title of an earlier study in the references, not as a finding established by this paper; yeast appears only in a referenced title. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [17] Wickramasinghe, 2013, Human Inositol Polyphosphate Multikinase Regulates Transcript-Selective Nuclear MRNA Export to Preserve Genome Integrity, Mol. Cell source

      The Results and Discussion support a role for human IPMK in mRNA export, and the Introduction describes transcriptional effects of its yeast homolog. The Discussion also reports impaired AKT activation in an IPMK mouse model, but our copy does not establish the broader claims about nutrient sensing or growth factor signaling (searched those terms). (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [18] Saiardi, 2000, Inositol Polyphosphate Multikinase (ArgRIII) Determines Nuclear MRNA Export in Saccharomyces Cerevisiae, FEBS Lett. source
    • cites [19] Steger, 2003, Regulation of Chromatin Remodeling by Inositol Polyphosphates, Science source

      The paper’s Abstract identifies yeast ARG82/IPK2 as a nuclear inositol polyphosphate kinase and reports its role in phosphate-responsive transcription. It also states that Arg82 kinase activity is required for efficient mRNA export from the nucleus. Our copy does not establish roles in growth factor signaling or nutrient sensing broadly, nor does it address mammalian embryonic development. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [20] Beon, 2022, Inositol Polyphosphate Multikinase Physically Binds to the SWI/SNF Complex and Modulates BRG1 Occupancy in Mouse Embryonic Stem Cells, Elife source

      The Introduction (no page available) identifies IPMK as originally cloned from yeast and describes its roles in metabolic and signaling pathways and transcriptional control; the Results (no page available) also show effects on gene expression in mouse embryonic stem cells. Our copy does not establish a role in mRNA transport. Its embryoid-body experiments do not establish that IPMK is essential for mammalian embryonic development. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [21] Blind, 2012, Direct Modification and Activation of a Nuclear Receptor-PIP2 Complex by the Inositol Lipid Kinase IPMK, Sci. Signal. source

      The Introduction identifies IPMK as required for adaptive transcriptional responses, and the Results report that its activity enhances SF-1-mediated transcription. The References list a yeast study linking IPMK to nuclear mRNA export, but the paper does not establish the claimed roles in nutrient sensing or growth-factor signaling. Page numbers are unavailable in our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [22] Xu, 2013, Inositol Polyphosphate Multikinase Is a Transcriptional Coactivator Required for Immediate Early Gene Induction, Proc. Natl. Acad. Sci. USA source
    • cites [23] Kim, 2011, Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase, Cell Metab. source

      The Introduction and Results report IPMK’s role in amino-acid signaling to mTOR and its involvement in insulin-stimulated mTORC2 signaling. The Introduction identifies IPMK in yeast, and the Discussion reports that IPMK knockout mice die early in development. Our copy does not establish a role for IPMK in mRNA transport or transcription regulation; transcription appears only in cited reference titles. Page numbers are unavailable in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK is implicated in neurodegeneration, cancer, and inflammation.

    “Over two decades, multidisciplinary research has unveiled its far-reaching biological roles and implications in diverse diseases, including neurodegeneration, cancer, and inflammation.”
    Quote in the paperSubstantial claim7 of 8 sources checked
    • cites [28] Ahn, 2021, Myeloid IPMK Promotes the Resolution of Serum Transfer-Induced Arthritis in Mice, Anim. Cells Syst. source

      The Discussion reports an association involving IPMK, Alzheimer’s disease, and immune-mediated diseases, while the paper’s findings concern resolution of inflammatory arthritis in mice. The Introduction also describes IPMK’s broad signaling roles. Neither section establishes an implication in cancer; the mentions of p53 and cancer in the Introduction and References do not support that part of the claim. Page numbers were not provided in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [29] Kim, 2017, Inositol Polyphosphate Multikinase Promotes Toll-like Receptor-Induced Inflammation by Stabilizing TRAF6, Sci. Adv. source

      The Introduction and Results describe IPMK’s role in Toll-like receptor–induced inflammation, and the Discussion reports effects in mouse models of sepsis and endotoxemia. Although the Introduction describes IPMK as a signaling hub, our copy does not establish the claimed implications in neurodegeneration or cancer (searched for both). Page numbers were not available in the indexed passages. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [30] Bang, 2014, Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action, Mol. Endocrinol. source

      The Abstract (page unavailable) describes IPMK as a multifunctional signaling protein and reports its involvement in pathways including Akt, mTOR and AMPK. It does not link IPMK to neurodegeneration, cancer or inflammation; its discussion of a cancer syndrome concerns LKB1, not IPMK. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [31] Lee, 2020, Inositol Polyphosphate Multikinase in Adipocytes Is Dispensable for Regulating Energy Metabolism and Whole Body Metabolic Homeostasis, Am. J. Physiol. Endocrinol. Metab. source
    • cites [32] Yokoyama, 2016, Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease, JAMA Neurol. source

      The Discussion (page not provided) links IPMK to Alzheimer’s and Huntington’s disease and suggests a role in neurodegeneration. It also describes IPMK as an inflammation-associated gene, but the paper does not state that IPMK is implicated in cancer; its discussion of p53-mediated transcription and cell death does not establish that disease claim. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [33] Park, 2022, Gut Epithelial Inositol Polyphosphate Multikinase Alleviates Experimental Colitis via Governing Tuft Cell Homeostasis, Cell. Mol. Gastroenterol. Hepatol. source

      The Conclusions passage links an IPMK mutation to familial small-intestinal carcinoids, and the Discussion reports that epithelial IPMK depletion worsened experimental colitis. These support the cancer and inflammation examples. Our copy does not establish an implication of IPMK in neurodegeneration, so it does not support the full list. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [34] Reilly, 2023, Loss of PI3k Activity of Inositol Polyphosphate Multikinase Impairs PDK1-Mediated AKT Activation, Cell Migration, and Intestinal Homeostasis, iScience source

      The Introduction (page not provided) links an IPMK mutation to familial intestinal carcinoids and describes IPMK as a putative risk gene for inflammatory bowel disease. The Discussion (page not provided) also suggests IPMK activity may affect Crohn disease risk. The paper does not link IPMK to neurodegeneration, so it supports only part of the attributed disease list. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [35] Sei, 2015, A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase, Gastroenterology source

      The Discussion (page not supplied) links an IPMK mutation to familial small-intestinal carcinoid tumors and describes effects on proliferation and apoptosis, supporting the cancer portion. The passages do not link IPMK to neurodegeneration or inflammation; searches for those terms found no such link in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    The N-lobe ATP grasp fold, along with the hinge, guides ATP to transfer its γ phosphate to InsP3 to yield InsP4, which is further phosphorylated to InsP5.

    “The N-lobe ATP grasp fold, along with the hinge, guides the ATP to transfer its γ phosphate to the InsP3 (1, 4, 5) cradled in the cavity created by the IP helices to yield InsP4 (1,3,4,5; 3-kinase activity), which is further phosphorylated to InsP5 (1,3,4,5, 6; 6-kinase activity).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [41] Seacrist, C.D., and Blind, R.D. (2018). Crystallographic and Kinetic Analyses of Human IPMK Reveal Disordered Domains Modulate ATP Binding and Kinase Activity. Sci. Rep., 8. source

      The Results section, “Crystallography shows ΔIPMK maintains the ATP-grasp fold” (page unavailable), identifies an N-terminal ATP-grasp domain and an inositol-phosphate-binding helix. The Discussion describes a proposed ATP clamp, and the Methods describe γ-phosphate transfer in a PIP2 kinase assay. Our copy does not establish the hinge-guided mechanism or the specified InsP3 → InsP4 → InsP5 sequence and phosphorylation positions. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [42] Wang, 2017, Structural Features of Human Inositol Phosphate Multikinase Rationalize Its Inositol Phosphate Kinase and Phosphoinositide 3-Kinase Activities, J. Biol. Chem. source

      The nucleotide-binding section says HsIPMK clasps ATP between its N- and C-lobes, joined by a hinge. The inositol-phosphate-binding and structure sections describe Ins(1,4,5)P3 in the active-site pocket and its successive phosphorylation to Ins(1,3,4,5)P4 and Ins(1,3,4,5,6)P5. But the paper could not visualize ATP’s γ-phosphate and says direct transfer *may* occur; the claim presents that structural mechanism more definitively than the paper does. Page numbers were not available in our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK-generated PIP3 facilitates polymerization of nuclear actin, essential for recruitment of ATR and participating in replication stress and DNA repair.

    “Two notable studies by Wang et al. [59] and Lamm et al. [60] elucidated that IPMK-generated PIP3 facilitates the polymerization of nuclear actin, essential for the recruitment of ATR (ataxia telangiectasia and Rad3-related protein) and participating in replication stress and DNA repair processes.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [59] Wang, 2017, DNA Damage Causes Rapid Accumulation of Phosphoinositides for ATR Signaling, Nat. Commun. source

      The Results report that IPMK activity is needed for PIP3 accumulation and that ATR recruitment depends on actin polymerization; the Discussion links nuclear phosphoinositides and actin to ATR recruitment at DNA-damage sites. The paper mentions ATR’s response to stalled replication forks, but the passages do not establish that the IPMK–PIP3–actin pathway participates in replication stress. It also presents PIP3-mediated actin polymerization as likely, rather than directly established. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites [60] Lamm, 2020, Nuclear F-Actin Counteracts Nuclear Deformation and Promotes Fork Repair during Replication Stress, Nat. Cell Biol. source

      The Main Text (page unavailable) identifies an ATR–IPMK–mTOR pathway that regulates nuclear actin polymerization during replication stress and promotes replication fork repair. It does not identify IPMK-generated PIP3 as the mediator or say that nuclear actin polymerization is essential for ATR recruitment; instead, it places ATR upstream of the observed actin response. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    This interaction facilitates chromatin remodeling and transcriptional regulation in mammalian cells.

    “This interaction subsequently facilitates chromatin remodeling and transcriptional regulation in mammalian cells.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [20] Beon, 2022, Inositol Polyphosphate Multikinase Physically Binds to the SWI/SNF Complex and Modulates BRG1 Occupancy in Mouse Embryonic Stem Cells, Elife source

      The Abstract and Introduction report that IPMK binds the SWI/SNF complex and contributes to chromatin accessibility and transcription in mouse embryonic stem cells. The claim’s broader wording, “in mammalian cells,” extends that finding beyond the cell type studied. No page numbers are available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In mammalian cells, the ortholog of MCM1, SRF, activates immediate early genes.

    “In mammalian cells, the ortholog of MCM1, Serum Response Factor (SRF), activates immediate early genes [72,74].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [72] Chen, 2023, Mechanism of Action of the SWI/SNF Family Complexes, Nucleus source

      The Introduction discusses conservation of SWI/SNF complexes between yeast and mammals, and the Linker DNA recognition section discusses transcription factors, but neither addresses SRF as an MCM1 ortholog or its activation of immediate early genes. Searches for “Serum Response Factor SRF activates immediate early genes” and “MCM1 ortholog mammalian immediate early genes” found no passage supporting the claim. Page numbers were not available in our copy. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
    • cites [74] Spencer, 1996, Expression of the Serum Response Factor Gene Is Regulated by Serum Response Factor Binding Sites, J. Biol. Chem. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Both reported structures are in close agreement with a backbone root mean square deviation of 0.48 Å.

    “Both reported structures are in close agreement with a backbone root mean square deviation of 0.48 Å.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [41] Seacrist, C.D., and Blind, R.D. (2018). Crystallographic and Kinetic Analyses of Human IPMK Reveal Disordered Domains Modulate ATP Binding and Kinase Activity. Sci. Rep., 8. source
    • cites [42] Wang, 2017, Structural Features of Human Inositol Phosphate Multikinase Rationalize Its Inositol Phosphate Kinase and Phosphoinositide 3-Kinase Activities, J. Biol. Chem. source

      The Structure of human IPMK section compares the two ligand-bound HsIPMK complexes and reports near-perfect superimposition of their inositol phosphate groups, supporting close agreement in that respect. Neither that section nor the structure statistics in Table 1 report a 0.48 Å backbone root-mean-square deviation between the structures; the reported 0.111 Å value concerns ligand positions, not protein backbones. Page numbers are unavailable in our copy. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK binds to TRAF6 and stabilizes it by impeding its proteasomal degradation, thereby activating NF-kB downstream.

    “IPMK binds to TRAF6 and stabilizes it by impeding its proteasomal degradation, thereby activating NF-kB downstream [29].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [29] Kim, 2017, Inositol Polyphosphate Multikinase Promotes Toll-like Receptor-Induced Inflammation by Stabilizing TRAF6, Sci. Adv. source
  • May combine two claims.

    Premisecitation

    Loss of IPMK's kinase activity impairs membrane localization of PDK1 and subsequently affects phosphorylation of MLC by ROCK1.

    “In addition to integrin regulation, Reilly et al. [34] proposed an alternative mechanism whereby the loss of IPMK’s kinase activity impairs the membrane localization of 3-phosphoinositide-dependent protein kinase 1 (PDK1) and subsequently affects the phosphorylation of myosin light chain (MLC) by Rho-associated protein kinase 1 (ROCK1).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [34] Reilly, 2023, Loss of PI3k Activity of Inositol Polyphosphate Multikinase Impairs PDK1-Mediated AKT Activation, Cell Migration, and Intestinal Homeostasis, iScience source
  • May combine two claims.

    Premisecitation

    Conditional deletion of IPMK in the intestine significantly hinders spontaneous proliferation of intestinal epithelial cells and AKT signaling.

    “The study demonstrated that conditional deletion of IPMK in the intestine significantly hinders the spontaneous proliferation of intestinal epithelial cells and AKT signaling.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [34] Reilly, 2023, Loss of PI3k Activity of Inositol Polyphosphate Multikinase Impairs PDK1-Mediated AKT Activation, Cell Migration, and Intestinal Homeostasis, iScience source
  • May combine two claims.

    Premisecitation

    Depletion of IPMK in cells or mouse tissue significantly diminishes HDAC3 activation and results in increased histone acetylation.

    “Recent research has shown that depletion of IPMK—responsible for synthesizing HOIPs—in cells or mouse tissue significantly diminishes HDAC3 activation and results in increased histone acetylation [78,79].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [78] Chatterjee, S., Preval, L.V., Sin, Z., Tran, N., Ritter, K., Su, X.B., Centlivre, J.P., Ragsac, S.J., Van, R., and Park, S. (2024). Inositol Hexaphosphate (InsP6) Activates the HDAC1/3 Epigenetic Axis to Maintain Intestinal Barrier Function. bioRxiv. source
    • cites [79] Sowd, G.A., Stivison, E.A., Chapagain, P., Hale, A.T., Poland, J.C., Rameh, L.E., and Blind, R.D. (2024). IPMK Regulates HDAC3 Activity and Histone H4 Acetylation in Human Cells. bioRxiv. source

      The Abstract and Figure 6 description report that IPMK deletion in human U251 cells decreased HDAC3 activity and increased histone H4 acetylation. The paper does not report those outcomes in mouse tissue; its Discussion mentions a mouse knockout only in connection with unchanged Class I HDAC protein levels. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Catalytic transfer is aided by two Mg2+ ions interacting with D385 to facilitate contact with the α- and β-phosphates of ATP; this aspartate position is conserved throughout the IP-kinase family.

    “The catalytic transfer is aided by two Mg2+ ions interacting with D385 to facilitate contact with the α- and β-phosphates of ATP; this aspartate position is conserved throughout the IP-kinase family.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [41] Seacrist, C.D., and Blind, R.D. (2018). Crystallographic and Kinetic Analyses of Human IPMK Reveal Disordered Domains Modulate ATP Binding and Kinase Activity. Sci. Rep., 8. source

      The Discussion (page not available) mentions a published human IPMK structure bound to an ATP analog and two magnesium ions. It does not say that the ions interact with D385, facilitate contact with ATP’s α- and β-phosphates, or that this aspartate is conserved throughout the IP-kinase family; searches for D385 and phosphate-contact terms found no such passage. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Removal of the region that contains the NLS results in lower affinity for the InsP3 substrate and perturbs kinetic parameters significantly.

    “Furthermore, removal of the region that contains the NLS [42] (Figure 2A,B) also results in lower affinity for the InsP3 substrate and perturbs kinetic parameters significantly.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [42] Wang, 2017, Structural Features of Human Inositol Phosphate Multikinase Rationalize Its Inositol Phosphate Kinase and Phosphoinositide 3-Kinase Activities, J. Biol. Chem. source
  • May combine two claims.

    Premisecitation

    IPMK loss does not affect RAD51 transcription, but impairs the mRNA's cytoplasmic export and translation, reducing RAD51 protein production.

    “While IPMK loss does not affect RAD51 transcription, it impairs the mRNA’s cytoplasmic export and translation, ultimately reducing RAD51 protein production.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [61] Choi, 2019, A Nuclear Phosphoinositide Kinase Complex Regulates P53, Nat. Cell Biol. source

      The Results section on PIPKIα and p53 stability reports that PIPKIα deletion reduced mutant p53 protein while leaving p53 mRNA levels unaffected; no page number is available in our copy. Searches for IPMK, RAD51, mRNA export, and translation found no passage addressing the claimed RAD51 mechanism. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK is a rate-limiting enzyme in the HOIP pathway, significantly impacting cellular inositol phosphate levels.

    “IPMK is a rate-limiting enzyme in the Higher Order Inositol Phosphate (HOIP) pathway, significantly impacting cellular inositol phosphate levels [14].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [14] Guha, 2019, IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration, Cell Rep. source

      The Introduction (page unavailable) says IPMK physiologically generates IP4 and IP5, supporting its role in higher-order inositol phosphate production. The Results describe inositol profiling to verify IPMK activity, but the cited passages do not establish that IPMK is rate-limiting or that it significantly changes cellular inositol phosphate levels. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    IPMK stabilizes the mTORC1 complex and facilitates amino acid sensing in cells.

    “Kim et al. [23] were the first to demonstrate that IPMK stabilizes the mTORC1 complex and facilitates amino acid sensing in cells.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [23] Kim, 2011, Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase, Cell Metab. source
  • May combine two claims.

    Premisecitation

    IPMK converts PIP2 to PIP3, which is necessary for SF-1-mediated transcriptional activation.

    “IPMK converts PIP2 to PIP3, which is necessary for SF-1-mediated transcriptional activation (Figure 3B).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [21] Blind, 2012, Direct Modification and Activation of a Nuclear Receptor-PIP2 Complex by the Inositol Lipid Kinase IPMK, Sci. Signal. source

      The Results section, “IPMK Specifically Phosphorylates PIP2 when bound to SF-1” (page unavailable), shows that IPMK converts SF-1-bound PIP2 to PIP3. “Reducing IPMK Activity Impairs SF-1 Transcriptional Activity” reports that IPMK knockdown lowers SF-1 target-gene expression and concludes that PIP3 generation enhances transcription; it does not establish that the conversion is strictly necessary for transcriptional activation. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    SWI/SNF complex dysregulation is linked to cancer.

    “The SWI/SNF complex is indeed a crucial player in chromatin remodeling, and its dysregulation is linked to cancer.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [72] Chen, 2023, Mechanism of Action of the SWI/SNF Family Complexes, Nucleus source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    SWI/SNF complex interacts directly with key tumor suppressors and oncogenes such as RB, BRCA1, c-MYC, and MLL, impacting genes crucial for cell proliferation, differentiation, and survival.

    “The SWI/SNF complex interacts directly with key tumor suppressors and oncogenes such as RB, BRCA1, c-MYC, and MLL, impacting genes crucial for cell proliferation, differentiation, and survival [72].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [72] Chen, 2023, Mechanism of Action of the SWI/SNF Family Complexes, Nucleus source

      The Future perspective (page unavailable) says defective mSWI/SNF complexes deregulate gene transcription, and the disease-associated mutations section links these complexes to cancer. But the passages do not establish direct interactions with RB, BRCA1, c-MYC, or MLL, or the claimed effects on genes governing proliferation, differentiation, and survival; searches for those names and terms found no supporting passage. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    IPMK was initially identified in yeast.

    “Initially identified in yeast and later recognized as essential for mammalian embryonic development, IPMK has transitioned from a niche interest to a focal point in studies of nutrient sensing, growth factor signaling, mRNA transport, and transcription regulation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Traditionally, InsP3 derived from PIP2 by PLC has been considered the primary precursor for InsP4 production.

    “Traditionally, InsP3, derived from Phosphatidylinositol 4,5-bisphosphate (PIP2) by phospholipase C (PLC), has been considered the primary precursor for InsP4 (InsP 1,4,5,6) production [37].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [37] Irvine, 2001, Back in the Water: The Return of the Inositol Phosphates, Nat. Rev. Mol. Cell Biol. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    InsP3 stimulates intracellular calcium release.

    “The discovery of inositol 1,4,5-trisphosphate (InsP3) as a critical secondary messenger that stimulates intracellular calcium release [1] revolutionized our understanding of cellular signaling.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [1] Berridge, 1984, Inositol Trisphosphate, a Novel Second Messenger in Cellular Signal Transduction, Nature source
  • May combine two claims.

    Interpretationnone given

    IPMK has emerged as a versatile regulator of cellular functions with both kinase-dependent and independent roles.

    “IPMK, in particular, has emerged as a versatile regulator of cellular functions, exhibiting both kinase-dependent and independent roles.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    IPMK generates only PI(3,4,5)P3 as its product, unlike class I PI3K which generates multiple products.

    “Specifically, IPMK generates only PI (3,4,5) P3 as its product [26], highlighting its unique enzymatic specificity in lipid kinase activity.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [26] Resnick, 2005, Inositol Polyphosphate Multikinase Is a Nuclear PI3-Kinase with Transcriptional Regulatory Activity, Proc. Natl. Acad. Sci. USA source
    • cites [36] Vanhaesebroeck, 2001, Synthesis and Function of 3-Phosphorylated Inositol Lipids, Annu. Rev. Biochem. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    IPMK may shuttle between the nucleus and the cytoplasm.

    “Consistent with this, Meyer et al. [45] identified a nuclear export signal (NES, amino acid 170–179) in addition to IPMK’s known C-terminal nuclear localization signal (NLS), suggesting that IPMK may shuttle between these compartments.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    The roles of HOIP and PIP3 in nuclear function remain largely uncharted.

    “IPMK is a distinctive protein that serves both as an inositol kinase and a lipid kinase, and its enrichment in the nucleus highlights a novel area for exploring the roles of HOIP and PIP3 in nuclear function, a field that remains largely uncharted.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Loss of IPMK's lipid kinase activity disrupts PDK1 localization, stabilizing the ROCK1/RhoE inhibitory complex and preventing ROCK1-mediated MLC phosphorylation, thus hindering cell migration.

    “The loss of IPMK’s lipid kinase activity disrupts PDK1 localization, stabilizing the ROCK1/RhoE inhibitory complex and preventing ROCK1-mediated MLC phosphorylation [55], thus hindering cell migration (Figure 3B-i).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [55] Pinner, 2008, PDK1 Regulates Cancer Cell Motility by Antagonising Inhibition of ROCK1 by RhoE, Nat. Cell Biol. source
  • May combine two claims.

    Premisecitation

    Upon activation of cell migration, RhoE dissociates from ROCK1, allowing ROCK1 to phosphorylate MLC, promoting actin polymerization.

    “Upon activation of cell migration, RhoE dissociates from ROCK1, allowing ROCK1 to phosphorylate MLC, which promotes actin polymerization and facilitates cell movement.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [55] Pinner, 2008, PDK1 Regulates Cancer Cell Motility by Antagonising Inhibition of ROCK1 by RhoE, Nat. Cell Biol. source
  • May combine two claims.

    Interpretationnone given

    IPMK serves both as an inositol kinase and a lipid kinase.

    “IPMK is a distinctive protein that serves both as an inositol kinase and a lipid kinase, and its enrichment in the nucleus highlights a novel area for exploring the roles of HOIP and PIP3 in nuclear function, a field that remains largely uncharted.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    IPMK is essential for maintaining regenerative capacity of both liver and intestinal tissues.

    “These findings highlight the essential role of IPMK in maintaining the regenerative capacity of both liver and intestinal tissues.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    IPMK acts as a nuclear PI3K, forming p53-PIP3 complexes that recruit and activate AKT within the nucleus.

    “This finding highlights a membrane-independent mechanism where IPMK acts as a nuclear PI3K, forming p53-PIP3 complexes that recruit and activate AKT within the nucleus, representing a new dimension in cell survival regulation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    It remains unclear which specific physiological or cellular functions are principally regulated by IPMK.

    “It remains unclear which specific physiological or cellular functions are principally regulated by IPMK.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    IPMK is distributed in both the nucleus and the cytoplasm.

    “Their work with epifluorescence microscopy suggested that IPMK is distributed in both the nucleus and the cytoplasm.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [45] Meyer, 2012, Nucleocytoplasmic Shuttling of Human Inositol Phosphate Multikinase Is Influenced by CK2 Phosphorylation, Biol. Chem. source
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    A significant knowledge gap persists regarding IPMK's primary regulatory pathway in maintaining cellular homeostasis.

    “Overall, it indicates that despite extensive research on IPMK’s diverse roles in cell signaling, function, and physiology, a significant knowledge gap persists regarding its primary regulatory pathway in maintaining cellular homeostasis.”
    Quote in the paperNot a substantial claim
45 of 45
  • The paper relies on this without support.

    A significant knowledge gap remains in understanding higher-order inositol phosphates and their biological functions.

    “While the importance of InsP3 is well-established, a significant knowledge gap remains in our understanding of higher-order inositol phosphates (HOIPs) and their biological functions.”
  • The paper relies on this without support.

    IPMK activates mTORC1.

    “For example, while IPMK is known to activate mTORC1, it remains unclear whether this activation occurs on the lysosome, in the cytoplasm, or within the nucleus, where mTORC1 has recently been found.”
  • The paper relies on this without support.

    mTORC1 has recently been found in the nucleus.

    “For example, while IPMK is known to activate mTORC1, it remains unclear whether this activation occurs on the lysosome, in the cytoplasm, or within the nucleus, where mTORC1 has recently been found.”
  • The paper relies on this without support.

    HOIP and PIP3 are small molecules that bind to specific protein sites and modulate their activity.

    “As HOIP and PIP3 are small molecules that bind to specific protein sites and modulate their activity, pinpointing their target proteins and characterizing these binding sites could pave the way for developing new synthetic drugs that block HOIP or PIP3 binding, thereby offering therapeutic benefits for disease treatment.”
  • The paper relies on this without support.

    HOIP is water-soluble.

    “Moreover, since HOIP is water-soluble, exploring its supplementation in food or developing in vivo delivery methods could be advantageous for treating diseases where IPMK deficiency is a primary factor.”
5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • A kinase-dependent YAP mechanism appears under kinase-independent functions

    Minor

    Section 4.3 presents its examples as kinase-independent functions, but its YAP subsection attributes the effect to an IPMK enzymatic product and says inhibiting IPMK activity disrupts it.

  • Wickramasinghe study is cited as reference 61

    Minor

    The passage attributes the investigation to Wickramasinghe et al. [61], but the paper's reference 61 is by Choi et al.; Wickramasinghe et al. is listed as reference 17.

  • TRAF6 interaction regions are assigned inconsistent exon numbers

    Minor

    The TRAF6 row labels regions 93-124 and 208-416 as exons 4 and 6. Elsewhere in the table, the 125-182 region is identified as exon 4, so the TRAF6 row's 93-124 region cannot also be exon 4.

  • Reference 89 concerns a different kinase, not IPMK

    Minor

    The passage attributes IPMK expression and a reporter mouse model to Verbsky et al. [89], but the cited reference identifies its subject as inositol pentakisphosphate 2-kinase and the tissue distribution of that kinase.

4 of 4

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mishra, S. H., Chatterjee, S., Viera-Preval, L., & Guha, P.
Affiliations
  • National Institute of Standards and Technology (US)
  • University of Nevada, Las Vegas (US)
  • Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas, NV 89154, USA
Corresponding author
Guha, Prasun
Venue
Biomolecules
Publisher
MDPI AG
Published
2025-09-01
Volume
15
Issue
9
Pages
1266
ISSN
2218-273X (ISSN-L)
OpenAlex
W4413880124
Cited by
1
References
104
Citations by year
2026: 1
FWCI
0.09
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Nevada (NIH R16GM154726)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
inositol polyphosphate multikinase, inositol tetrakisphosphate, phosphatidylinositol 3,4,5-trisphosphate, lipid kinase activity, nutrient sensing, growth factor signaling, mRNA transport, transcriptional regulation, embryonic development, neurodegeneration, cancer, inflammation, therapeutic target
MeSH terms
Animals, Humans, Neoplasms, Signal Transduction, Phosphotransferases (Alcohol Group Acceptor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-30.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-30.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review